Frontier
Deep tech: chips, robotics, space, and bio
Ten trillion parameters and a renounced shortcut: what ByteDance's biggest training run actually signals
The number is a target, not a model. The real news is that China's best funded consumer AI company says it will stop copying and start spending.
Anthropic starts designing its own chips, and its own politics
In twenty four hours the lab moved on its two deepest dependencies: the silicon it rents from four suppliers and a Washington that told agencies to stop using Claude.
Ten proofs for $2,000: what OpenAI's Astra drop actually establishes
The price tag is marketing arithmetic. The Lean certificates underneath it are the part that changes how AI claims get checked.
Sixty hours against two years: an AI model just retired a post-quantum candidate
Claude Mythos Preview found a structural weakness in HAWK that human review missed for two years. The break is not practical. The precedent is.
Kimi K3 makes open weights a scale contest, and scale is the point
Moonshot just published a 2.8 trillion parameter model anyone can download. Almost no one can run it, and that may be exactly the strategy.
The frontier stopped moving up and started moving down
Anthropic shipped a model that costs about half of its most capable one and beats it on several benchmarks, which is a statement about margins more than about intelligence.
Sweden has the rocks. Europe still lacks the refinery.
Uppsala chemists want to design magnets around whatever Swedish ore actually contains, a smart inversion of the usual problem that runs straight into the parts of the supply chain Sweden does not yet own.
A Mars camera built for rocks measured an interstellar comet
Tianwen-1 pointed a surface-imaging camera at 3I/ATLAS from Mars orbit and came away with dust physics, not just a picture.
Waymo Adds Cities and Freeways, and Now the Test Is the Math
Waymo launched driverless rides in four more cities on July 8 and now carries riders on freeways in three metros. The scaling is real. Whether the unit economics scale with it is the open question.
Helion Gets the Paperwork Before It Gets the Power
Helion holds the first fusion plant operating licenses in the US. That clears a real gate, but the licenses govern radiation safety, not net electricity, and 2028 still looks ambitious.
Tesla Converts a Car Line to Robots, and Buys Itself Room to Miss
Tesla is turning its Fremont Model S and X line into an Optimus V3 factory this summer. The ramp is real, but Musk dropped his volume targets and the robot has no announced outside buyers.
One pad, one explosion, a grounded program
A static-fire blast that destroyed a New Glenn and damaged Launch Complex 36 exposed the risk Blue Origin built into its manifest: a single operational pad with no backup.
Starship V3 delivered its payload and lost its booster
The first Block 3 Starship opened its bay in orbit and dropped 20 satellite simulators, a real step toward useful payloads, while the booster failure showed reuse economics are still unproven.
A $2.1 billion bet before a single approval
Isomorphic Labs raised one of the largest rounds in AI drug discovery to move from proving its models to proving they can produce a medicine, a test the money buys time for but cannot pass.
Blue Origin caught the booster and lost the payload
New Glenn's first booster reuse put Blue Origin in a club of two, but an upper-stage failure that stranded a customer satellite showed reuse is only half the reliability problem.
Artemis II proved the capsule, not the landing
Four astronauts flew around the Moon and came home, validating Orion for deep space while leaving the harder half of the program, a crewed landing, still on paper.
Helion's D-T milestone is real, and it is not the milestone that matters
A private machine hitting 150 million degrees and measurable fusion is a genuine step; the number that decides commercial fusion, net electricity, is still absent from the announcement.
Isomorphic's IsoDDE moves AI drug design from prediction to pipeline
A unified engine that predicts structure, binding, and antibodies in one system is the step that turns AlphaFold's insight into something a drug program can actually run on.
The magnet is the whole bet: inside SPARC's first coil
Commonwealth Fusion Systems began hanging the 20 tesla magnets that its entire tokamak thesis rests on, converting a physics claim into an assembly schedule the market can now track.